The authors subjected wild-type and apolipoprotein E-deficient (ApoE−/−) mice to middle cerebral artery occlusion and identified that the PPARα agonist fenofibrate decreased the susceptibility of ApoE−/− mice to stroke and also decreased infarct volume in wild-type animals [9]. Here, PPARA is linked to stroke disorder.